Afdeling for Klinisk Fysiologi og Nuklearmedicin

Medicin og biovidenskab

1. Positron-Emission Tomography 100%
2. Fluorodeoxyglucose F18 42%
3. Neoplasms 35%
4. Magnetic Resonance Imaging 35%
5. Brain 34%
6. Positron Emission Tomography Computed Tomography 29%
7. Perfusion 29%
8. Therapeutics 22%
9. Urokinase Plasminogen Activator Receptors 22%
10. Healthy Volunteers 20%
11. Radiotherapy 20%
12. Single-Photon Emission-Computed Tomography 19%
13. Cerebrovascular Circulation 19%
14. Receptor, Serotonin, 5-HT2A 19%
15. 64Cu-DOTATATE 19%
16. Glucose 17%
17. Rubidium-82 17%
18. Biomarkers 15%
19. Blood Pressure 15%
20. Neuroendocrine Tumors 14%
21. Radionuclide Imaging 14%
22. Migraine Disorders 14%
23. Molecular Imaging 14%
24. Schizophrenia 13%
25. Antipsychotic Agents 13%
26. Lung 13%
27. Nuclear Medicine 13%
28. Heterografts 13%
29. Glioblastoma 12%
30. Neuroimaging 12%
31. Type 2 Diabetes Mellitus 12%
32. Placebos 12%
33. Tomography 12%
34. Exercise 12%
35. Serotonin 12%
36. 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane 12%
37. Radioisotopes 11%
38. Myocardial Perfusion Imaging 11%
39. Neoplasm Metastasis 11%
40. Denmark 11%
41. Lung Neoplasms 10%
42. Cimbi-36 10%
43. Survival 10%
44. Kidney 10%
45. Randomized Controlled Trials 10%
46. White Matter 10%
47. Bone and Bones 10%
48. Muscles 10%
49. Magnetic Resonance Spectroscopy 10%
50. Brain Neoplasms 9%
51. Swine 9%
52. Guidelines 9%
53. Psychotic Disorders 9%
54. Hodgkin Disease 9%
55. Glioma 8%
56. Hypertension 8%
57. Glucagon-Like Peptide 1 8%
58. Ligands 8%
59. Tumor Burden 8%
60. Head and Neck Neoplasms 8%
61. Squamous Cell Carcinoma of Head and Neck 8%
62. Pediatrics 8%
63. Inflammation 8%
64. Myocardial Infarction 8%
65. Stroke Volume 8%
66. Receptors, Serotonin, 5-HT4 8%
67. Skeletal Muscle 8%
68. Recurrence 8%
69. Somatostatin Receptors 8%
70. Cluster Headache 8%
71. Heart Failure 8%
72. SB 207145 8%
73. Serotonin Plasma Membrane Transport Proteins 8%
74. Population 8%
75. Glomerular Filtration Rate 8%
76. Multiple Sclerosis 8%
77. Cross-Over Studies 8%
78. Mortality 8%
79. Alzheimer Disease 7%
80. Peptides 7%
81. Blood-Brain Barrier 7%
82. Injections 7%
83. Biopsy 7%
84. Deep Learning 7%
85. Single Photon Emission Computed Tomography Computed Tomography 7%
86. Liposomes 7%
87. Prostatic Neoplasms 7%
88. Type 1 Diabetes Mellitus 7%
89. Coronary Artery Disease 7%
90. HIV 7%
91. Prospective Studies 7%
92. Atherosclerosis 7%
93. Headache 7%
94. Hypoxia 7%
95. Photons 7%
96. Brain Natriuretic Peptide 7%
97. Liraglutide 7%
98. Calcitonin Gene-Related Peptide 7%
99. 1,4,7-triazacyclononane-N,N',N''-triacetic acid 7%
100. Glucagon-Like Peptide-1 Receptor 7%